ArticleAmerican journal of respiratory and critical care medicine2013

Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.

Zahoor Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.